5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)furan-2-carbaldehyde, 95.0%, 5g

2,2'-(4,5,6-Trifluorobenzene-1,3-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 97%, 100mg

5-(TERT-BUTOXYCARBONYLAMINO-METHYL)CYCLOHEX-1-ENECARBOXYLIC ACID, 95.0%, 500mg

2-(3-Boronophenyl)acetic acid, 95.0%, 250mg

4-(Hydroxyamino)quinoline N-Oxide>97.0%(T)1g

(S)-3-Aminobutanenitrile hydrochloride, 97.0%, 10g

(S)-tert-Butyl 4-isopropyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 98%, 250mg

4'-chloro-2-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

GC capillary column ROTI®Cap-1, 10 m, 0.10 mm, 0.10 µm, 1 Piece(s)

(3-cyclopropylphenyl)boronic acid, 95%, 10g

2,4-Dichloro-3,6-dimethylpyridine, 95.0%, 5g

3-Bromobenzamide, 98.0%, 1g

tert-Butyl 7-formyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, 97%, 1g